Related Experiment Video
Updated: Aug 25, 2026
High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses
Published on: May 5, 2014
Alternative approaches for efficient inhibition of hepatitis C virus RNA replication by small interfering RNAs
Jan Krönke1, Ralf Kittler, Frank Buchholz
1Department of Molecular Virology, Hygiene Institute, University of Heidelberg, D-69120 Heidelberg, Germany.
Abstract:
Persistent infection with hepatitis C virus (HCV) is a leading cause of chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma. It has recently been shown that HCV RNA replication is susceptible to small interfering RNAs (siRNAs), but the antiviral activity of siRNAs depends very much on their complementarity to the target sequence. Thus, the high degree of sequence diversity between different HCV genotypes and the rapid evolution of new quasispecies is a major problem in the development of siRNA-based gene therapies. For this study, we developed two alternative strategies to overcome these obstacles. In one approach, we used endoribonuclease-prepared siRNAs (esiRNAs) to simultaneously target multiple sites of the viral genome. We show that esiRNAs directed against various regions of the HCV coding sequence as well as the 5' nontranslated region (5' NTR) efficiently block the replication of subgenomic and genomic HCV replicons. In an alternative approach, we generated pseudotyped retroviruses encoding short hairpin RNAs (shRNAs). A total of 12 shRNAs, most of them targeting highly conserved sequence motifs within the 5' NTR or the early core coding region, were analyzed for their antiviral activities. After the transduction of Huh-7 cells containing a subgenomic HCV replicon, we found that all shRNAs targeting sequences in domain IV or nearby coding sequences blocked viral replication. In contrast, only one of seven shRNAs targeting sequences in domain II or III had a similar degree of antiviral activity, indicating that large sections of the NTRs are resistant to RNA interference. Moreover, we show that naive Huh-7 cells that stably expressed certain 5' NTR-specific shRNAs were largely resistant to a challenge with HCV replicons. These results demonstrate that the retroviral transduction of HCV-specific shRNAs provides a new possibility for antiviral intervention.
Insights
Hepatitis C virus (HCV) gene therapy faces challenges due to viral diversity. This study shows that endoribonuclease-prepared small interfering RNAs (siRNAs) and retroviral short hairpin RNAs (shRNAs) effectively inhibit HCV replication, offering new antiviral strategies.
Area of Science:
- Virology
- Molecular Biology
- Gene Therapy
Background:
- Persistent hepatitis C virus (HCV) infection leads to severe liver diseases, including cirrhosis and cancer.
- HCV RNA replication is targeted by small interfering RNAs (siRNAs), but viral genetic diversity and rapid evolution hinder siRNA-based therapies.
- Developing effective siRNA strategies requires overcoming sequence variability and targeting conserved regions.
Purpose of the Study:
- To develop and evaluate novel strategies for inhibiting HCV RNA replication using RNA interference.
- To overcome the challenges posed by HCV genetic diversity and quasispecies evolution in developing gene therapies.
- To assess the efficacy of endoribonuclease-prepared siRNAs (esiRNAs) and short hairpin RNAs (shRNAs) delivered via retroviruses against HCV.
Main Methods:
- Developed esiRNAs targeting multiple sites across the HCV genome, including coding regions and the 5' non-translated region (5' NTR).
- Generated pseudotyped retroviruses encoding 12 different shRNAs targeting conserved HCV sequences, particularly in the 5' NTR and early core coding regions.
- Transduced Huh-7 cells harboring HCV replicons with esiRNAs and shRNAs; analyzed antiviral activity and stable resistance in naive cells.
Main Results:
- esiRNAs targeting various HCV regions, including the 5' NTR, efficiently blocked subgenomic and genomic HCV replicon replication.
- Retrovirally delivered shRNAs targeting conserved sequences in the 5' NTR (domain IV) and nearby coding regions effectively inhibited viral replication.
- Cells stably expressing 5' NTR-specific shRNAs demonstrated significant resistance to subsequent HCV replicon challenge, while targeting domains II or III showed limited efficacy.
Conclusions:
- Both esiRNAs and retrovirally delivered shRNAs represent viable strategies for inhibiting HCV replication, addressing challenges of viral diversity.
- Targeting conserved regions, especially within the 5' NTR, is crucial for effective RNA interference-based antiviral activity against HCV.
- Retroviral transduction of HCV-specific shRNAs offers a promising new avenue for developing antiviral interventions against persistent HCV infection.
Related Concept Videos
02:30siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
01:30Inhibitors of Viral Protein Synthesis
01:23RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
01:23RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
02:15Experimental RNAi
01:25Inhibitors Of Virion Release